This page shows the publications D. Moody has written about Mycolic Acids.
CD1b-mycolic acid tetramers demonstrate T-cell fine specificity for mycobacterial lipid tails. Eur J Immunol. 2017 09; 47(9):1525-1534.
Ultralong C100 mycolic acids support the assignment of Segniliparus as a new bacterial genus. PLoS One. 2012; 7(6):e39017.
Total Synthesis of a Mycolic Acid from Mycobacterium tuberculosis. Angew Chem Int Ed Engl. 2020 05 04; 59(19):7555-7560.
Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells. Immunol Lett. 1999 Jan; 65(1-2):85-91.
An Antibacterial ß-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis. Angew Chem Int Ed Engl. 2018 01 02; 57(1):348-353.
Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLoS Comput Biol. 2009 Aug; 5(8):e1000489.
CD1b Tetramers Broadly Detect T Cells That Correlate With Mycobacterial Exposure but Not Tuberculosis Disease State. Front Immunol. 2020; 11:199.
The molecular basis of CD1-mediated presentation of lipid antigens. Immunol Rev. 1999 Dec; 172:285-96.
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 1997 Oct 10; 278(5336):283-6.
Mycobacterium tuberculosis SigM positively regulates Esx secreted protein and nonribosomal peptide synthetase genes and down regulates virulence-associated surface lipid synthesis. J Bacteriol. 2006 Dec; 188(24):8460-8.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.